Introduction Primary Immunodeficiency (PI) disorders affect the immune system, making individuals highly susceptible to infections. Immunoglobulin replacement therapy is the standard treatment for PI, traditionally administered intravenously (IVIG) or subcutaneously (SCIG). The addition of recombinant human hyaluronidase to SCIG facilitates larger-
40 Reached
Case of Adolescent with Severe Macrocytic Anaemia
50824 Reached500 Comments51 Likes
Woman with Persistent Lyme Disease
57 Reached
Male Complaining of Bilateral Knee Pain and Gait Disturbance
840 Reached5 Comments1 Likes
Hearing Loss in Newborn with Neck Swelling
1164 Reached15 Comments11 Likes
Efficacy of MP-AzeFlu Against Futicasone Propionate for the Treatment of Allergic Rhinitis in Children
8036 Reached9 Comments4 Likes